Información de la revista
Lo más leído
4469
Evolving portal hypertension through Baveno VII recommendationsManuel Mendizabal, Guilherme Grossi Lopes Cançado, Agustín Albillos
Ann Hepatol. 2024;29:101180
4469
Acceso a texto completo
3986
A multisociety Delphi consensus statement on new fatty liver disease nomenclatureMary E. Rinella, Jeffrey V. Lazarus, Vlad Ratziu, Sven M. Francque, Arun J. Sanyal, Fasiha Kanwal, Diana Romero, Manal F. Abdelmalek, ... NAFLD Nomenclature consensus group
Ann Hepatol. 2024;29:101133
3986
Acceso a texto completo
3279
Administration of silymarin in NAFLD/NASH: A systematic review and meta-analysisShudi Li, Fei Duan, Suling Li, Baoping Lu
Ann Hepatol. 2024;29:101174
3279
Acceso a texto completo
3150
Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cellsShuguang Pan, Ying Hu, Lang Gan, Jiejuan Lai, Ping Zheng, YuJun Zhang, Ling Shuai, Yan Jiang, ... Yu He
Ann Hepatol. 2024;29:101279
3150
Acceso a texto completo
2731
Alcohol-associated liver disease: Epidemiology and managementHelena Hernández-Évole, Natalia Jiménez-Esquivel, Elisa Pose, Ramón Bataller
Ann Hepatol. 2024;29:101162
2731
Acceso a texto completo
2673
From NAFLD to MASLD: When metabolic comorbidity mattersShan Hong, Lei Sun, Yiwei Hao, Ping Li, Yuling Zhou, Xiuxia Liang, Julong Hu, Hongshan Wei
Ann Hepatol. 2024;29:101281
2673
Acceso a texto completo
1931
The burden of liver disease in Latin AmericaLuis Antonio Díaz, Marcela Villota-Rivas, Francisco Barrera, Jeffrey V. Lazarus, Marco Arrese
Ann Hepatol. 2024;29:101175
1931
Acceso a texto completo
1755
Why a pinch of zinc in liver disease mattersKurt Grüngreiff, Dirk Reinhold, Wolfgang Maret
Ann Hepatol. 2024;29:101152
1755
Acceso a texto completo
1465
Schistosomiasis: A neglected cause of liver disease in the PhilippinesAlexander M. Sy
Ann Hepatol. 2024;29:101166
1465
Acceso a texto completo
1327
From evidence to clinical practice: Bridging the gap of new liver cancer therapies in Latin America.Federico Piñero, Ezequiel Mauro, Paola Casciato, Alejandro Forner
Ann Hepatol. 2024;29:101185
1327
Acceso a texto completo
1069
Liquid biopsy: New opportunities for precision medicine in hepatocellular carcinoma careInah Marie C. Aquino, Devis Pascut
Ann Hepatol. 2024;29:101176
1069
Acceso a texto completo
1066
Optimal ALT threshold for the automated diagnosis of MASLD: A population-based study using iLFTJeremy Lee, Christopher J. Byrne, Paul N. Brennan, Iain MacPherson, Eleanor Dow, John F. Dillon
Ann Hepatol. 2024;29:101280
1066
Acceso a texto completo
1001
Prevalence of occult hepatitis B virus infection and characterisation of hepatitis B surface antigen mutants among adults in western CroatiaMarina Bubonja-Šonje, Dolores Peruč, Maja Abram, Bojana Mohar-Vitezić
Ann Hepatol. 2024;29:101156
1001
Acceso a texto completo
978
A data-driven approach to decode metabolic dysfunction-associated steatotic liver diseaseMaria Jimenez Ramos, Timothy J. Kendall, Ignat Drozdov, Jonathan A. Fallowfield
Ann Hepatol. 2024;29:101278
978
Acceso a texto completo
918
Overall and subgroup prevalence of non-alcoholic fatty liver disease and prevalence of advanced fibrosis in the United States: An updated national estimate in National Health and Nutrition Examination Survey (NHANES) 2011-2018Tongtong Wang, Yuzhi Xi, Annaswamy Raji, Michael Crutchlow, Gail Fernandes, Samuel S Engel, Xiao Zhang
Ann Hepatol. 2024;29:101154
918
Acceso a texto completo
889
Global prevalence of occult HBV infection in children and adolescents: A systematic review and meta-analysisJiaying Wu, Jiayao He, Hongmei Xu
Ann Hepatol. 2024;29:101158
889
Acceso a texto completo
874
NAFLD is associated with less severe liver fibrosis in chronic hepatitis B: A multi-center, retrospective studyRenling Yao, Sufang Lu, Ruifei Xue, Jian Wang, Yuanwang Qiu, Yuxin Chen, Jiacheng Liu, Li Zhu, ... Chao Wu
Ann Hepatol. 2024;29:101155
874
Acceso a texto completo
836
Stemness markers in hepatocellular carcinoma of Eastern vs. Western population: Etiology matters?Caecilia HC Sukowati, Korri El-Khobar, Chyntia Olivia Maurine Jasirwan, Juferdy Kurniawan, Rino Alvani Gani
Ann Hepatol. 2024;29:101153
836
Acceso a texto completo
816
Ending stigmatizing language in alcohol and liver disease: A liver societies' statementAnn Hepatol. 2024;29:101143
816
Acceso a texto completo
787
The landscape of inpatient admissions for alcoholic hepatitis in the era of early liver transplantationShahana Prakash, Tomohiro Tanaka
Ann Hepatol. 2024;29:101169
787
Acceso a texto completo